Evidence that p53-Mediated Cell-Cycle-Arrest Inhibits Chemotherapeutic Treatment of Ovarian Carcinomas

• Carlos S. Moreno,

  Affiliations Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America, Winship Cancer Institute, Atlanta, Georgia, United States of America

  ⨯
• Lilya Matyunina,

  Affiliations School of Biology, Georgia Institute of Technology, Atlanta, Georgia, United States of America, Ovarian Cancer Institute, Atlanta, Georgia, United States of America

  ⨯
• Erin B. Dickerson,

  Affiliations School of Biology, Georgia Institute of Technology, Atlanta, Georgia, United States of America, Ovarian Cancer Institute, Atlanta, Georgia, United States of America

  ⨯
• Nina Schubert,

  Affiliations School of Biology, Georgia Institute of Technology, Atlanta, Georgia, United States of America, Ovarian Cancer Institute, Atlanta, Georgia, United States of America

  ⨯
• Nathan J. Bowen,

  Affiliations School of Biology, Georgia Institute of Technology, Atlanta, Georgia, United States of America, Ovarian Cancer Institute, Atlanta, Georgia, United States of America

  ⨯
• Sanjay Logani,

  Affiliation Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Benedict B. Benigno,

  Affiliation Ovarian Cancer Institute, Atlanta, Georgia, United States of America

  ⨯
• John F. McDonald

  *To whom correspondence should be addressed. E-mail: john.mcdonald@biology.gatech.edu

  Affiliations School of Biology, Georgia Institute of Technology, Atlanta, Georgia, United States of America, Ovarian Cancer Institute, Atlanta, Georgia, United States of America

  ⨯